Evidence map›Paper›PMID 41171096›Full record

ArticleThe Journal of cell biology2025

Tubulin regulates stability and localization of STMN2 by binding preferentially to its soluble form.

Xiang Deng, Gary A Bradshaw, Marian Kalocsay, Timothy Mitchison

Abstract read
In one paragraph

Article in The Journal of cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Xiang DengDepartment of Systems Biology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-9058-4964
Gary A BradshawLaboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-9724-6100
Marian KalocsayDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-4187-5829
Timothy MitchisonDepartment of Systems Biology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-7781-1897

Funding

Cell and Chemical Biology of MicrotubulesR35GM131753 · NIGMS · HARVARD MEDICAL SCHOOL · PI Timothy J Mitchison · 2019 to 2026
$6.4M
Cancer Prevention and Research Institute of Texas RR220032NIGMS NIH HHS R35 GM131753NIGMS NIH HHS R35GM131753
6 · The paper itself

Abstract

The small, tubulin-binding protein STMN2 is highly expressed in neurons and is implicated in amyotrophic lateral sclerosis. STMN2 degrades rapidly and accumulates at axotomy sites, suggesting fast turnover is crucial for its neuroprotective function. We show that STMN2 was primarily degraded by the ubiquitin-proteasome system. Its membrane-targeting N-terminal domain promoted fast turnover, whereas its tubulin-binding domain promoted stabilization. Proximity labeling and imaging showed that tubulin binding reduced STMN2 targeting to trans-Golgi network membranes. Pull-down assays showed that tubulin binds preferentially to soluble over membrane-bound STMN2. Our observations suggest that STMN2 interconverts between a soluble, tubulin-bound form and a membrane-bound, tubulin-free form, and is rapidly degraded when released from both membranes and tubulin. We propose that tubulin binding sequesters and stabilizes STMN2, while its neuroprotective function involves an unknown membrane activity.

Indexed as

TubulinAnimalsCell MembraneHEK293 CellsHumansProteasome Endopeptidase ComplexProtein BindingProtein StabilityProtein TransportProteolysisSolubilitytrans-Golgi NetworkProteasome Endopeptidase ComplexTubulin

Identifiers

PMID41171096
PMCPMC12803766

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.